A breast cancer drug may be used to treat pancreatic cancer

Share This Post

The survival rate of pancreatic cancer is very low. In the past 40 years, the survival rate has not changed significantly. Finding effective treatments is an urgent challenge for researchers. For many years, tamoxifen has been used to treat breast cancer because it inhibits estrogen to stimulate breast tumor growth. Recently, studies have shown that tamoxifen may be used to treat pancreatic cancer. The research team proved that tamoxifen can help change the physical environment of mouse tumor growth, regulate scar tissue development, inflammation and immune response. The research results are published in “EMBO Report”.

Pancreatic cancer, like most solid tumors, is surrounded by a large amount of connective tissue. The stiff scar-like tissues are like scaffolding around tumors. They block the delivery of drugs by preventing chemotherapy drugs from reaching the tumor. They also regulate the growth and spread of tumors. The formation of connective tissue in pancreatic tumors is driven by pancreatic stellate cells (PSCs), which are strengthened by the application of physical force and remodeling of the tissue structure.

When the researchers studied the mouse pancreatic tumor model, they discovered interactions between cells around the pancreatic tumor, and also studied how tamoxifen changed the physical environment around the pancreatic tumor. Tamoxifen has the ability to inhibit the connective tissue around PSC sclerosis tumors and prevent the surrounding environment from becoming hard. Tamoxifen regulates the immune response and can inhibit the invasion and spread of cancer cells. Moreover, the cells in the pancreatic tumor are exposed to very little oxygen, which creates a protective mechanism: when the oxygen level drops, the cell releases a molecule called hypoxia inducible factor (HIF), which helps cancer cells Survive under conditions. But tamoxifen can inhibit the production of HIF, making cancer cells susceptible to low oxygen levels and more likely to die. But this work is currently carried out on cell culture and mouse models, so more research is needed before it can be applied to human patients.

Subscribe To Our Newsletter

Get updates and never miss a blog from Cancerfax

More To Explore

Risk of developing secondary tumors following CAR-T cell therapy is minimal - A Stanford Study
CAR T-Cell therapy

Risk of developing secondary tumors following CAR-T cell therapy is minimal – A Stanford Study

CAR-T cell therapy, a groundbreaking cancer treatment, carries a risk of developing secondary tumors. This occurs due to the therapy’s potential to cause genetic mutations or alter the immune system’s regulation. Secondary malignancies can arise from these changes, presenting a significant long-term risk for patients. Continuous monitoring and research are crucial to understanding and mitigating these risks, ensuring safer outcomes for those undergoing CAR-T cell therapy.

Seattle Children's Hospital to Start CAR T-Cell Clinical Trial for Pediatric Lupus Patients
CAR T-Cell therapy

Seattle Children’s Hospital to Start CAR T-Cell Clinical Trial for Pediatric Lupus Patients

Seattle Children’s Hospital is launching a groundbreaking CAR T-cell clinical trial for pediatric lupus patients. This innovative approach harnesses the body’s immune cells to target and eliminate lupus-affected cells, offering new hope for young patients with this autoimmune disorder. The trial represents a significant advancement in lupus treatment, aiming to improve outcomes and reduce long-term complications for children suffering from this challenging condition.

Need help? Our team is ready to assist you.

We wish a speedy recovery of your dear and near one.

Start chat
We Are Online! Chat With Us!
Scan the code

Welcome to CancerFax !

CancerFax is a pioneering platform dedicated to connecting individuals facing advanced-stage cancer with groundbreaking cell therapies like CAR T-Cell therapy, TIL therapy, and clinical trials worldwide.

Let us know what we can do for you.

1) Cancer treatment abroad?
2) CAR T-Cell therapy
3) Cancer vaccine
4) Online video consultation
5) Proton therapy